SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Lexaria Bioscience Corp. (LEXXW) News

Follow Lexaria Bioscience Corp. (LEXXW) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 11 public stories across 11 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol LEXXW Asset equity Sector Markets 90 days 7 Last 0.0397 Updated Oct 15, 2026, 01:10 PM UTC Open live news feed Open LEXXW chart & news
L Lexaria reports results from GLP-1 animal study The company announced results from animal study GLP-1-A26-1. EQUITY | Oct 15, 2026, 01:10 PM UTC L LEXX LEXXW - Lexaria Updates Financial Position LEXX LEXXW - Lexaria Updates Financial Position NEWS | Sep 17, 2026, 01:10 PM UTC M Lexaria closes warrant exercises raising about $5.9 million gross EQUITY | Sep 09, 2026, 08:15 PM UTC L Lexaria exercise of warrants raises about $5.9M gross proceeds Lexaria announced the exercise of warrants for approximately $5.9 million in gross proceeds. EQUITY | Sep 08, 2026, 12:00 PM UTC L LEXX LEXXW - Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference LEXX LEXXW - Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference EQUITY | Sep 04, 2026, 01:20 PM UTC L Lexaria receives a USD tax rebate payment Lexaria receives a USD tax rebate payment, per the latest update. EQUITY | Sep 01, 2026, 01:15 PM UTC L Lexaria enters material transfer agreement with PegBio Lexaria said it enters a material transfer agreement with PegBio; no catalyst, terms, or financial impact were supplied in the alert. MNA | Aug 13, 2026, 01:00 PM UTC H Lexaria Sets Reverse Stock Split Date Lexaria announces reverse stock split effective date EQUITY | Jul 30, 2026, 03:00 PM UTC L Lexaria Updates Business Development (TheNewswire) EQUITY | Jul 06, 2026, 01:10 PM UTC M LEXX: Begins Dosing Lexaria's human study GLP-1-H26-7 has begun dosing on schedule EQUITY | Jun 25, 2026, 01:10 PM UTC L LEXX: Animal Study Begins Lexaria's animal study GLP-1-A26-1 has begun dosing on schedule EQUITY | Jun 23, 2026, 01:26 PM UTC